Monday, June 27, 2011

Atossa Raises $6.6M For Molecular Diagnostics

Seattle-based Atossa Genetics, a developer of molecular diagnostics for breast cancer, said this morning that it has raised $6.6M in a new funding round. Source of the new funding was not announced. The firm said the round was oversubscribed, exceeding the original target of $6.0M for the round. Atossa Genetics is developing a new, molecular diagnostic risk assessment product for breast cancer. More information »